stars 1 stars 2 stars 3

CardioNet was just the beginning. Founded on an innovative, patented technology, the result of years of research and development, the company received FDA approval for its core monitoring technology and was the first to provide real-time, heartbeat-by-heartbeat, ECG monitoring, analysis and response, at home or away, 24/7/365. BioTelemetry Healthcare is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. The Company provides cardiologists and electrophysiologists who prefer to use a single source of cardiac monitoring services with a full spectrum of solutions, ranging from the differentiated Mobile Cardiac Outpatient Telemetry™ (“MCOT™”) service to wEvent, event, Holter, Pacemaker and International normalized ratio (“INR”) monitoring. INR monitoring is a measurement of blood coagulation in the circulatory system and is prescribed for patients on long term anticoagulation therapy.

CardioNet Questions

The CardioNet annual revenue was $476.3 million in 2026.

James Sweeny is the Chairman and CEO of CardioNet.

223 people are employed at CardioNet.

CardioNet is based in Malvern, Pennsylvania.

Top CardioNet Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users